KHALI

SHARED STORY

Loading story



Get Khali



Open in app

Free on the App Store

#root { display: none !important; } html, body { height: auto !important; } body { overflow: auto !important; margin: 0; background: #07111f; color: #f4f4f5; font: 16px/1.6 system-ui, sans-serif; } article { box-sizing: border-box; max-width: 760px; margin: 0 auto; padding: 48px 24px 72px; } h1 { font-size: clamp(2rem, 7vw, 3.5rem); line-height: 1.05; } h2 { margin-top: 2rem; } a { color: #64b5ff; }

technology · 3 outlets · 3 linked reports

Anthropic Launches Claude Science and Its Own Drug-Discovery Program

2026-07-06

AI-assisted: summaries and questions may be incomplete or incorrect. Verify important details with the linked original reporting.

Summary

Anthropic released Claude Science in beta on June 30, 2026 — an AI 'workbench' for researchers with 60+ curated skills across genomics, proteomics, structural biology and cheminformatics.
Alongside it, the company is starting its own drug-discovery program targeting 'neglected' diseases, focused on preclinical work.
The push builds on Anthropic's ~$400M April 2026 acquisition of Coefficient Bio for life-sciences expertise.

The question

AI research tools will meaningfully accelerate drug discovery for overlooked diseases.

Original reporting

Open this story in Khali

Get Khali on the App Store